Waiting twenty years for your discovery to gain FDA approval might test some researchers' resolve. But Mark Goodman, kept his eye on the prize: a new and improved imaging agent. We created a molecule, FACBC, and studied it in cancer cell. We discovered that the radiotracer was especially good for looking at prostate cancer and superior to the current imaging agent. With the construction of a new research building and radiopharmacy lab inventor meets patient. Learn more here:
Музыка
Фильмы
ТВ Шоу
Категории видео
